Last week, on The Big Wakeup Call, Ryan and I discussed a new Alzheimer’s drug that was zooming towards public use. And I mean ZOOOOOOOMING! From a preliminary, and vague, research paper released in November of 2019, to opening trials on humans in February of 2020 kind of zooming. That kind of time line is essentially unheard of in the world of medicines. I’ve written, on several occasions, about the trials and tribulations facing new treatments for Alzheimer’s. The FDA’s own rules would seem to preclude any such speed, but here we are. The company, called Green Valley, is based in Shanghai and reports to the Chinese government. In 2007 they released a “cancer cure” that was so ineffective it led to millions of dollars in lawsuits and complaints.
Quick update:The FDA’s last posting of Fast Tracked drugs and treatments was in September of last year. Updates are supposed to post every January and July. [Read more…] about Fast Tracking For Fun and Profit